Envestnet Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $49.1M | Sell |
92,802
-40,222
| -30% | -$18.6M | 0.01% | 876 |
|
|
2026
Q1 | $63.9M | Buy |
133,024
+8,080
| +6% | +$4.14M | 0.02% | 705 |
|
|
2025
Q4 | $70.2M | Buy |
124,944
+11,295
| +10% | +$6.41M | 0.02% | 600 |
|
|
2025
Q3 | $58.4M | Buy |
113,649
+10,745
| +10% | +$4.69M | 0.02% | 706 |
|
|
2025
Q2 | $32.3M | Buy |
102,904
+9,118
| +10% | +$2.74M | 0.01% | 964 |
|
|
2025
Q1 | $28.6M | Sell |
93,786
-7,941
| -8% | -$2.67M | 0.01% | 971 |
|
|
2024
Q4 | $33.8M | Buy |
101,727
+2,811
| +3% | +$953K | 0.01% | 885 |
|
|
2024
Q3 | $33M | Sell |
98,916
-4,173
| -4% | -$1.59M | 0.01% | 921 |
|
|
2024
Q2 | $42.5M | Sell |
103,089
-2,809
| -3% | -$1.11M | 0.01% | 742 |
|
|
2024
Q1 | $42.8M | Sell |
105,898
-6,072
| -5% | -$2.13M | 0.02% | 728 |
|
|
2023
Q4 | $34.3M | Buy |
111,970
+18,025
| +19% | +$4.87M | 0.01% | 766 |
|
|
2023
Q3 | $22.7M | Buy |
93,945
+26,320
| +39% | +$6.73M | 0.01% | 907 |
|
|
2023
Q2 | $16.2M | Sell |
67,625
-335,492
| -83% | -$69.7M | 0.01% | 1033 |
|
|
2023
Q1 | $8.05M | Buy |
403,117
+353,955
| +720% | +$73.2M | ﹤0.01% | 1362 |
|
|
2022
Q4 | $10.4M | Sell |
49,162
-3,540
| -7% | -$707K | 0.01% | 1169 |
|
|
2022
Q3 | $8.28M | Buy |
52,702
+1,773
| +3% | +$283K | ﹤0.01% | 1218 |
|
|
2022
Q2 | $7.62M | Buy |
50,929
+16,150
| +46% | +$2.34M | ﹤0.01% | 1293 |
|
|
2022
Q1 | $5.69M | Sell |
34,779
-1,310
| -4% | -$216K | ﹤0.01% | 1520 |
|
|
2021
Q4 | $7.85M | Sell |
36,089
-693
| -2% | -$145K | ﹤0.01% | 1329 |
|
|
2021
Q3 | $6.96M | Buy |
36,782
+2,151
| +6% | +$392K | ﹤0.01% | 1344 |
|
|
2021
Q2 | $6.12M | Buy |
34,631
+731
| +2% | +$126K | ﹤0.01% | 1391 |
|
|
2021
Q1 | $5.56M | Sell |
33,900
-3,272
| -9% | -$500K | ﹤0.01% | 1352 |
|
|
2020
Q4 | $5.17M | Buy |
37,172
+4,186
| +13% | +$528K | ﹤0.01% | 1263 |
|
|
2020
Q3 | $3.69M | Sell |
32,986
-1,755
| -5% | -$203K | ﹤0.01% | 1309 |
|
|
2020
Q2 | $3.23M | Buy |
34,741
+5,330
| +18% | +$454K | ﹤0.01% | 1335 |
|
|
2020
Q1 | $2.16M | Buy |
29,411
+6,538
| +29% | +$568K | ﹤0.01% | 1381 |
|
|
2019
Q4 | $1.92M | Sell |
22,873
-990
| -4% | -$76.6K | ﹤0.01% | 1629 |
|
|
2019
Q3 | $2M | Sell |
23,863
-638
| -3% | -$48.2K | ﹤0.01% | 1538 |
|
|
2019
Q2 | $1.6M | Buy |
24,501
+16,667
| +213% | +$961K | ﹤0.01% | 1686 |
|
|
2019
Q1 | $462K | Sell |
7,834
-1,987
| -20% | -$119K | ﹤0.01% | 2397 |
|
|
2018
Q4 | $520K | Buy |
+9,821
| New | +$539K | ﹤0.01% | 2129 |
|
|
2018
Q1 | – | Sell |
-1,772
| Closed | -$64K | – | 2912 |
|
|
2017
Q4 | $64K | Buy |
+1,772
| New | +$62.1K | ﹤0.01% | 2244 |
|
Other funds holding MEDP
WA
Envestnet Asset Management's MEDP Position: Q2 2026 in Review
Envestnet Asset Management reduced its Medpace (MEDP) stake by 30% in Q2 2026, selling an estimated $18.6M and leaving 92,802 shares worth $49.1M. The position accounts for 0.01% of the portfolio, ranked #876.
Envestnet Asset Management first reported a position in MEDP in Q4 2017 and has held it in 32 quarters since. The position peaked at $70.2M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Envestnet Asset Management held 92,802 shares of Medpace worth $49.1M as of Q2 2026.
- Envestnet Asset Management sold 40,222 Medpace shares in Q2 2026, an estimated $18.6M.
- Medpace made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #876 holding.
- Envestnet Asset Management first reported a position in Medpace in Q4 2017 and has held it in 32 quarters since.
- Envestnet Asset Management's Medpace position peaked at $70.2M in Q4 2025.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.